Test yourself answer: plantar soft tissue foot mass with insufficiency-type stress fractures.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7701953 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2161 (Electronic) Linking ISSN: 03642348 NLM ISO Abbreviation: Skeletal Radiol Subsets: MEDLINE
    • Publication Information:
      Publication: Berlin : Springer Verlag
      Original Publication: Berlin, New York, Springer International.
    • Subject Terms:
      Fractures, Stress*/diagnostic imaging ; Metatarsal Bones* ; Diabetic Foot*; Humans ; Foot ; Lower Extremity ; Biomechanical Phenomena ; Stress, Mechanical
    • References:
      Folpe AL. Phosphaturic mesenchymal tumors: a review and update. Semin Diagn Pathol. 2019;36(4):260–8. https://doi.org/10.1053/j.semdp.2019.07.002 . ISSN 0740-2570. (PMID: 10.1053/j.semdp.2019.07.00231301876)
      Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59:1442–54. (PMID: 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q3545439)
      Hudairy RE, Meliti A, Mokhtar G, Alanazi M. Phosphaturic mesenchymal tumor: a case report of a rare entity. Cureus. 2022;14(2):e22712. https://doi.org/10.7759/cureus.22712 . (PMID: 10.7759/cureus.22712353861728967444)
      Abrahamsen B, Smith CD, Minisola S. Epidemiology of tumor-induced osteomalacia in Denmark. Calcif Tissue Int. 2021;109(2):147–56. https://doi.org/10.1007/s00223-021-00843-2 . (PMID: 10.1007/s00223-021-00843-2338186538273058)
      Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, ... Matsumoto T. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J. 2015;62(9):811–816.
      Pelo S, Gasparini G, Garagiola U, D’Amato G, Saponaro G, Doneddu P, Todaro M, Moro A. Phosphaturic mesenchymal tumor, an unusual localization in head and neck. J Surg Case Rep. 2018;2018(5):rjy091. https://doi.org/10.1093/jscr/rjy091 . (PMID: 10.1093/jscr/rjy091299424636007331)
      Oyama N, Kojima-Ishii K, Toda N, Matsuo T, Tocan V, Ohkubo K, Oba U, Koga Y, Setsu N, Yamada Y, Kohashi K. Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review. Clin Pediatr Endocrinol. 2020;29(2):69–75. (PMID: 10.1297/cpe.29.69323133757160461)
      Fukumoto S. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment. Feb J Mol Endocrinol. 2021;66(2):R57–65. https://doi.org/10.1530/JME-20-0089 . (PMID: 10.1530/JME-20-008933295878)
      Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT. Tumour-induced osteomalacia Nat Rev Dis Primers. 2017;13(3):17044. https://doi.org/10.1038/nrdp.2017.44 . (PMID: 10.1038/nrdp.2017.44)
      Ghorbani-Aghbolaghi A, Darrow MA, Wang T. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss. Autops Case Rep. 2017;7(3):32–7. https://doi.org/10.4322/acr.2017.031 . (PMID: 10.4322/acr.2017.031290432085634432)
      Moran M, Paul A. Octreide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop. 2002;26:61–2. (PMID: 10.1007/s00264-001-0318-0119548533620857)
      Hesse E, Moessinger E, Rosenthal H, et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res. 2007;22:158–62. (PMID: 10.1359/jbmr.06090917014386)
      He Q, Zhang B, Zhang L, Chen Z, Shi X, Yi C, Wang X, Zhang X. Diagnostic efficiency of (68)Ga-DOTANOC PET/CT in patients with suspected tumourinduced osteomalacia. Eur Radiol. 2021;31(4):2414–21. (PMID: 10.1007/s00330-020-07342-233021702)
      Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40(1):e6–10. (PMID: 10.1097/RLU.000000000000046024999675)
      Frank FA, Gerber L, Cornelius A, Baumhoer D, Krieg AH. FGF-23 transmitted tumor-induced hypophosphatemic osteomalacia: a rare case of a young woman with recurrent fractures and review of the literature. J Bone Oncol. 2022;29:100413. (PMID: 10.1016/j.jbo.2022.100413)
      Shankar V, Pernick N. Phosphaturic Mesenchymal Tumor. Pathology Outlines - Phosphaturic Mesenchymal Tumor, 1 Nov. 2021. https://www.pathologyoutlines.com/topic/softtissuephosphaturic.html.
      Pal R, Bhadada SK, Singhare A, Bhansali A, Kamalanathan S, Chadha M, Chauhan P, Sood A, Dhiman V, Sharma DC, Saikia UN, Chatterjee D, Agashe V. Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr Connect. 2019;8(3):266–76. https://doi.org/10.1530/EC-18-0552 . (PMID: 10.1530/EC-18-0552307267716410764)
      Brandi ML, Clunie GPR, Houillier P, Suzanne M, de Beur J, Minisola S, Oheim R, Seefried L. Challenges in the management of tumor-induced osteomalacia (TIO). Bone. 2021;152:116064. https://doi.org/10.1016/j.bone.2021.116064 . ISSN 8756-3282. (PMID: 10.1016/j.bone.2021.11606434147708)
    • Publication Date:
      Date Created: 20231005 Date Completed: 20240110 Latest Revision: 20240116
    • Publication Date:
      20250114
    • Accession Number:
      10.1007/s00256-023-04470-w
    • Accession Number:
      37798375